BackEvotec SE Overview
Evotec SE - ADR

Evotec SE Target Price

Where could EVO trade next? Consensus target price: $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.73

Average Target Price

$3.0073.4% upside

2 analysts in the last 4 months

High: $4 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightSwayampakula Ramakanth$4131.2% upsideOpen
2026-07-15Macquarie$215.6% upsideOpen
2025-08-14H.C. WainwrightDouglas Tsao$7304.6% upsideOpen
2024-08-15H.C. WainwrightDouglas Tsao$8362.4% upsideOpen
2024-04-25H.C. WainwrightDouglas Tsao$11535.8% upsideOpen
2022-12-09H.C. Wainwright$12593.6% upsideOpen

Evotec SE (EVO) FAQ

Evotec SE posts a target price of $3. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $3 for EVO means covering analysts, on average, see the stock 73.4% upside of $1.73 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for EVO's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Evotec SE's other metric pages and overview cover the third.

Judging Evotec SE against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $3 here, then scan peer and history charts to see if the gap is persistent.